FDA Pulls Evusheld EUA; Former Adviser Urges EUA For Veru’s Drug

By Beth Wang / January 26, 2023 at 5:16 PM

FDA on Thursday (Jan. 26) revoked emergency use authorization for AstraZeneca’s coronavirus drug Evusheld (tixagevimab co-packaged with cilgavimab), coming as the agency faces pressure from a former adviser to authorize another COVID-19 drug, Veru’s proposed sabizabulin, which an FDA advisory committee narrowly recommended not be authorized last November.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.